No verified portrait

Owen Hughes

Director, C4 Therapeutics, Inc.

Since Jan 1, 2023.

Record corroboratedProfile not claimedPeople are not rated
Follow recordSave PDF
Record provenance
Alpha ID
alpha:person:owen-hughes
Record version
vpublic-0:d751713988987e9331980363e24189ce, published Sep 2, 2026
Newest evidence
Mar 30, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
Published claims
17 3 distinct sources
Evidence records
12 0 pinned
Source conflicts
0 None open
Current role
DirectorSince Jan 1, 2023
Board seats
3C4 Therapeutics, Inc., XOMA Royalty Corp
Committee seats
0None published

Governance snapshot

Inspect sources

Board oversight, responsibilities and disclosed experience. Each detail comes from this record’s published evidence.

Board service

C4 Therapeutics, Inc.

Current in the published record

Source disclosure: Apr 29, 2025. Status after that disclosure has not been established by this summary.

2023 to present

Appointment and supporting claims

XOMA Royalty Corp

Current in the published record

Source disclosure: Mar 30, 2026. Status after that disclosure has not been established by this summary.

2023 to present

Appointment and supporting claims

ImageneBio, Inc.

Current in the published record

Source disclosure: Apr 26, 2024. Status after that disclosure has not been established by this summary.

2022 to present

Appointment and supporting claims

Committee responsibilities

Committee memberships have not been published. This does not mean the person has no committee responsibilities.

How to read this record

Built from 3 distinct sources and 12 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public-role record. Alpha publishes facts about this person's role at an organization in the public Registry, drawn from regulatory filings and company statements, and nothing about private life. Any person or agent may read it. The subject can correct, dispute, or object. How this works

DIRECTOR APPOINTED

Owen Hughes seat on C4 Therapeutics, Inc., effective 2023-01-01.

EffectiveEffective Jan 1, 2023E7

Board service

Evidence

Seats held as a director, as published in the cited sources.

C4 Therapeutics, Inc. CurrentDirector, 2023 to presentOpen recordXOMA Royalty Corp CurrentDirector, 2023 to presentRecord pendingImageneBio, Inc. CurrentDirector, 2022 to presentOpen record
Supporting appointment claims (11)
Professional RoleDirector at C4 Therapeutics, Inc.
Source reportedE7
Professional RoleDirector at XOMA Royalty Corp
Source reportedE5
Professional RoleDirector at ImageneBio, Inc.
Source reportedE9
Board membershipServes on the board of C4 Therapeutics, Inc.
Board membershipServes on the board of ImageneBio, Inc.
Board membershipServes on the board of XOMA Royalty Corp
Board roleBoard role: Chair
Source reportedE8
Board roleBoard role: Director
Committee assignmentsNo committee assignment disclosed in the cited filing
Committee assignmentsCommittee assignments: Audit
Committee assignmentsCommittee assignments: Audit, Compensation

Committee experience

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Work experience

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Education, credentials, and certifications

Evidence

No education, credentials, or certifications are published in this record.

No published claims

No education, credentials, or certifications are published in this record.

AI, cyber, and technology accountability

Evidence
AI and ML experienceAI and ML experience: not identified in the cited filing
Technology backgroundTechnology background: not identified in the cited filing

Authority to act

Evidence and agent registry

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published professional roleDirector, C4 Therapeutics, Inc., from Jan 1, 2023
Source reportedE7
Published professional roleDirector, XOMA Royalty Corp, from Jan 1, 2023
Source reportedE5
Published professional roleDirector, ImageneBio, Inc., from Jan 1, 2022
Source reportedE9
Authority to bind the companyNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents acting on this authorityNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations grantedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Compensation and holdings

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Conflicts and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Cybersecurity experienceCybersecurity experience: not identified in the cited filing
Executive companyExecutive at XOMA Royalty Corporation
Executive titleExecutive title: Chief Executive Officer
Executive titleExecutive title: Chief Executive Officer (PEO)

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
  • Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
  • Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
  • Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencecorroborated
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Subject and corrections

Public-role doctrine

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis
Public role at an organization in the published Registry
Sources
12 evidence records cited. 0 with redistribution rights.
Never published
Home address, family, personal contacts, health, and history unrelated to the public role
Profile claimed
No
Open disputes
0
Identity ownership
unclaimed
Claim this profileSuggest an edit

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

Evidence

Authority and rights
  1. E1
    SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 28, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved May 16, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 11, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 28, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    sec proxy. Published Mar 30, 2026. Retrieved Apr 25, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    SEC EDGAR. sec filing. Published Apr 29, 2025. Retrieved May 15, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    sec proxy. Published Apr 29, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    SEC EDGAR. sec filing. Published Apr 26, 2024. Retrieved May 16, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    sec proxy. Published Apr 26, 2024. Retrieved Apr 29, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-0:d751713988987e9331980363e24189ce

vpublic-0:d751713988987e9331980363e24189ce published Sep 2, 2026
  • Owen Hughes seat on C4 Therapeutics, Inc., effective 2023-01-01.
  • Director at XOMA Royalty Corp, effective 2023-01-01.
  • Owen Hughes seat on ImageneBio, Inc., effective 2022-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:person:owen-hughes, version public-0:d751713988987e9331980363e24189ce. https://registry.alpha.ac/people/owen-hughes

Navigate

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:person:owen-hughes
  • Cite this recordOwen Hughes
  • Copy canonical URLregistry.alpha.ac/people/owen-hughes
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Owen HughesPerson
  • C4 Therapeutics, Inc.Company
  • ImageneBio, Inc.Company
  • Sections
    OverviewOwen Hughes
  • Board serviceOwen Hughes
  • CommitteesOwen Hughes
  • Work experienceOwen Hughes
  • Education and credentialsOwen Hughes
  • AI, cyber, technologyOwen Hughes
  • Authority to actOwen Hughes
  • CompensationOwen Hughes
  • Conflicts and accountabilityOwen Hughes
  • Other published claimsOwen Hughes
  • Coverage gapsOwen Hughes
  • Linked recordsOwen Hughes
  • MonitoringOwen Hughes
  • Subject and correctionsOwen Hughes
  • EvidenceOwen Hughes
  • Version historyOwen Hughes
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.